18
Views
0
CrossRef citations to date
0
Altmetric
Review

Compliance with inhalatory therapy: an increasingly recognized clinical outcome

Pages 449-456 | Published online: 09 Jan 2014

References

  • Lewis A. Noncompliance: a $100 billion problem. Remington. Rep. 5,14-15 (1997).
  • Haynes RB, Sackett DL, Gibson ES et al Improvement of medication compliance in uncontrolled hypertension. Lancet 1265–1268 (1976).
  • Rand CS, Nides M, Cowles MK, Wise RA, Connett J, for the Lung Health Study Research Group. Long-term metered-dose inhaler adherence in a clinical trial. Am. J. Respir. Grit. Care. Med. 152, 580–588 (1995). First study to assess long-term compliance in chronic obstructive pulmonary disease.
  • Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir. 8, 899–904 (1995).
  • Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur. Respir jJ. 9, 2346–2350 (1996).
  • Jones PW. Health status, quality of life and compliance. Eur Respir. Rev. 56, 243–246 (1998).
  • Turner J, Wright E, Mendella L, Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB study group. Chest 108, 394–400 (1995).
  • Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch. Intern. Med. 154, 1349–1352 (1994).
  • Park DC, Herzog C, Leventhal H eta]. Medication adherence in rheumatioid arthritis patients: Older is wiser. J. Am. Ceriatr Soc. 47, 172–183 (1999).
  • Nikolaus T, Kruse W, Bach M etal. Elderly patients problems with medication: An in-hospital and follow-up study. Eur. j Clin. Pharmacol. 49, 255–259 (1996).
  • Rand CS. Patient and regimen-related factors that influence compliance with asthma therapy. Eur. Respir. Rev 8, 270–274 (1998).
  • Chambers CV, Markson L. Diamond JJ et al Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 93, 88–94 (1999).
  • Urquhart J, de Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat. Med. 17, 251–267 (1998).
  • ••Describes the key issues in addressingcompliance.
  • Urquhart J. The electronic medication event monitor — lessons for pharmacotherapy. Gun. Pharmacokinet. 32, 345–356 (1997).
  • Willett WC, Sampson L, Stampfer MJ eta]. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. Epidemiol 122, 51–65 (1985).
  • Kristal AR, Shattuck AL, Williams A. Food frequency questionnaires for diet intervention research. 17th National Nutrient Databank. Conference, MD, USA, June 7–9 (1992). Int. Life Sci. Inst 17 (1994).
  • AA Stone, S Shiffman, JE Schwartz etal. Patient noncompliance with paper diaries. Br. Med.j 324, 1193–1194 (2002).
  • Tipaldy B, Crompton GK, Dewar MR etal The use of electronic diaries in respiratory studies. Drug • Inf J. 31, 759–764 (1997).
  • Hyland ME, Kenyon CAP, Allen R eta]. Diary keeping asthma: comparison of written and electronic methods. BE Med. J. 306, 487–489 (1993).
  • Kass MA, Meltzer D, Gordon M. A miniature compliance monitor for ophtalmology. Arch. Ophtal 102, 1550 (1984).
  • Urquhart J. Pharmacodynamics of variable patient compliance: implication for pharmaceutical value. Adv. Drug- Deliv. Rev 33(3), 207–219 (1998).
  • Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest 118, 290–295 (2000).
  • Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 104, 501–507 (1993).
  • Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest121, 871–876 (2002).
  • Kruse W Weber E. Dynamics of drug regimen compliance — its assessmentby microprocessor-based monitoring. Eur Clin. Pharmacol 38, 561–565 (1990).
  • Urquhart J. Role of patient compliance in clinical pharmacokinetics — a review of recent research. Clin. Pharmacokinet. 27, 202–215 (1994).
  • ••Describes the key issues in addressingcompliance.
  • Feely M, Cooke J, Price D. etal Low-dose phenobarbitone as an indicator of compliance with drug therapy. BE J. Gun. Pharmacol 24, 77–83 (1987).
  • Maenpaa H, Manninen V, Heinonen OR Compliance with medication in the Helsinki Heart Study. Eur. j Clin. Pharmacol 42,15–19 (1992).
  • •Useful resource for methods of assessment of compliance.
  • Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respir. Med. 83, 15–18 (1989).
  • Schron E, Czaikowski SM. Clinical Trials. In: Compliance in Healthcare and Research. Burke LE, Ockene IS (Eds). Futura Publishing, NY, USA (2001).
  • Davis CE. Prerandomization compliance screening: A statistician's view. In: The Handbook of Health Behaviour Change. Shumaker SA, Schron EB, Ockene JK (Eds). Springer, NY, USA, 342–347 (1990).
  • Anthonisen NR, Connett JE, Kiley JP etal Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAIVIA 272, 1497–1505 (1994).
  • Anthonisen NR, Connett JE, Enright Pl, Manfreda J and the Lung Health Study. Hospitalisations and mortality in the Lung Health Study. Am. J. Respir. Grit. Care. Med. 166, 333–339 (2002).
  • Kanner RE, Anthonisen NR, Connett JE, for the Lung Health Study Research Group. Lower respiratory illnesses promote FEV1 decline in current smokers but not in ex-smokers with mild chronic obstructive pulmonary disease. Results from the Lung Health Study. Am. J. Respir. Grit. Care. Med. 164, 358–364 (2001).
  • Rand CS, Wise RA, Nides M eta]. Metered-dose inhaler adherence in a clinical trial. Am. Rev. Respir Dis. 146, 1559–1564 (1992).
  • ••Seminal paper on compliance withinhalatory therapy.
  • Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest109, 963–968 (1996).
  • Braunstein GL, Trinquet G, Harper, Compliance Working Group. Compliance with nedocromil sodium ancilsalbutamol combination. Eur Respir. J. 9, 893–898 (1996).
  • Van der Palen J, Klein JJ, Rovers MM. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J.10, 652–657 (1997).
  • Urquhart J. The odds of the three nons when an aptly prescribed medicine isn't working: noncompliance, nonabsorption, nonresponse. BE j Clin. Pharmacol 54, 212–220 (2002).
  • Coutts JA, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch. Dis. ChilcI67, 332–333 (1992).
  • •Approaches compliance with inhalatory therapy in children.
  • Gibson NA, Ferguson AE, Autchinson TC eta]. Compliance with inhaled asthma medication in preschool children. Thorax 50,1274–1279 (1995).
  • •Approaches compliance with inhalatory therapy in children.
  • Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J. Allergy Clin. linaiunol. 98,1051–1057 (1996).
  • Esposito L. The effects of medication education on adherence to medication regimens in an elderly population. J. Adk NUTS. 21,935–943 (1995).
  • Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self medication program on knowledge of drugs and compliance with treatment in elderly patients. BE Med 310,1229–1231 (1995).
  • Bumier M, Schneider MP, Chiolero A, Fallab Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J. Hypertens. 19, 335–341 (2001).
  • Urquhart J. Some economic consequences of noncompliance. Cunent Hypertens. Repts. 3,473–80 (2001).
  • ••Good review of the economicconsequences of noncompliance.
  • Schlenk EA, Burke LE, Rand C. Behavioral strategies to improve medication-taking compliance. In: Compliance in Healthcare and Resealrh. Burke LE, Okene IS (Eds). Futura Publishing Company, NY (2001).
  • Morrow DG, Hier CM, Menard WE etal. The influence of a list format and category headers on age differences in understanding medication instructions. Exp. Aging. Res. 24,231–256 (1998).
  • Madge P, McColl J, Paton J. Impact of nurse-led home management training programme in children admitted to hospital with acute asthma: a randomized controlled study. Thotax52, 223–228 (1997).
  • Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 348, 383–386 (1996).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.